1. Interferon for Chinese patients with chronic hepatitis B e antigen-positive diseases—the controversy arises again?

   • George K. K. Lau

   Editorial 09 July 2014 Pages: 301 - 303

2. Yttrium-90 radioembolization for hepatocellular carcinoma in hepatitis B: commentary on a 103-patient Asian cohort

   • Laura Kulik
   • Riad Salem

   Editorial 23 July 2014 Pages: 304 - 307

3. Cirrhotic cardiomyopathy: review of pathophysiology and treatment

   • Maneerat Chayanupatkul
   • Suthat Liangpunsakul

   Review Article 11 April 2014 Pages: 308 - 315

   

4. Hedgehog signaling and radiation induced liver injury: a delicate balance

   • Rafi Kabarriti
   • Chandan Guha

   Review Article 08 May 2014 Pages: 316 - 320

   

5. Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma

   • Ivonne Nel
   • Paul David
   • Andreas-Claudius Hoffmann

   Review Article 03 June 2014 Pages: 321 - 329

6. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity

   • Chia-Lin Chen
   • Hidekazu Tsukamoto
   • Keigo Machida

   Review Article 20 June 2014 Pages: 330 - 338

   

7. The role of collateral veins detected by endosonography in predicting the recurrence of esophageal varices after endoscopic treatment: a systematic review

   • Laura Masalaite
   • Jonas Valantinas
   • Juozas Stanaitis

   Review Article 15 June 2014 Pages: 339 - 351

   

8. Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity

   • Blaire E. Burman
   • Paul Y. Kwo
   • Kris V. Kowdley

   Review Article 09 July 2014 Pages: 352 - 364

9. Patients with interferon-induced HBeAg seroconversion have a higher risk of HBV reactivation and HBeAg seroreversion

   • Chien-Hung Chen
   • Sheng-Nan Lu
   • Tsung-Hui Hu

   Original Article 31 May 2014 Pages: 365 - 374

   

10. A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients

    • Won Young Tak
    • Jin Mo Yang
    • Byung Chul Yoo

    Original Article Open access 25 May 2014 Pages: 375 - 381

    

11. Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries

    • Yock Young Dan
    • John B. Wong
    • Seng Gee Lim

    Original Article 27 June 2014 Pages: 382 - 394

    

12. Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma

    • Andrew Yu-Keat Khor
    • Ying Toh
    • Pierce Kah-Hoe Chow

    Original Article 05 April 2014 Pages: 395 - 404

    

13. Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia

    • Xia Ke
    • Yanke Chen
    • Zhinan Chen

    Original Article 03 May 2014 Pages: 405 - 414

    

14. Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet

    • Hayato Baba
    • Koichi Tsuneyama
    • Johji Imura

    Original Article 20 June 2014 Pages: 415 - 424

    

15. Pre-endurance training prevents acute alcoholic liver injury in rats through the regulation of damaged mitochondria accumulation and mitophagy balance

    • Guo-dong Ma
    • Yan-huan Liu
    • Xiao-di Wang

    Original Article 03 April 2014 Pages: 425 - 435

    

16. Procalcitonin as a marker of sepsis in alcoholic hepatitis

    • Kundan Kumar
    • Samir Mohindra
    • Gourdas Choudhuri

    Original Article 03 June 2014 Pages: 436 - 442

    

17. Vitamin D modulates biliary fibrosis in ABCB4-deficient mice

    • Katrin Hochrath
    • Caroline S. Stokes
    • Frank Lammert

    Original Article Open access 21 June 2014 Pages: 443 - 452